Systematic STI screening in unaccompanied migrant minors: a 6-year experience with urine-based NAAT
Systematic screening for sexually transmitted infections (STI), beyond serology, is not standard in arrival protocols for unaccompanied migrant minors (UMM). In 2020, our center incorporated urine-based nucleic acid amplification tests (NAAT)-based screening into the existing serology-based protocol (HIV, syphilis, hepatitis B/C), and we describe the additional diagnoses of STI identified through NAAT. We conducted a retrospective observational descriptive study (2020-2025) of 226 UMM (99.6% male) in Madrid undergoing serological screening for HIV, syphilis, hepatitis B and C, with additional urine-based multiplex PCR (NAAT) screening for STI. Urine-based NAAT, performed in 163/226 participants (72.1%), identified six positive cases (3.7%, 95% CI 1.4-7.8%) of C. trachomatis, M. genitalium, or Ureaplasma spp. Of these, four patients (2.5%, 95% CI 0.7-6.2%) had actionable infections that were treated. Serology identified no HIV (0/218) or hepatitis C cases (0/212), one syphilis case (0.5%, 95% CI 0.0-2.6%, 1/209), and three chronic hepatitis B cases (1.4%, 95% CI 0.3-3.9%, 3/221). None of the cases had symptoms recorded. CONCLUSION: Urine NAAT identified six infections (four actionable) not detectable by serology. However, three of eight patients with actionable infections were lost to follow-up, highlighting that the benefit of systematic screening depends on strengthening linkage-to-care alongside testing. WHAT IS KNOWN: • Serological screening (HIV, syphilis, hepatitis B/C) is standard in arrival health assessments for unaccompanied migrant minors, but systematic STI screening beyond serology is not routinely protocoled. • Systematic screening is especially valuable in this population, as follow-up is often limited by care fragmentation and transfers between reception centers. WHAT IS NEW: • Urine-based NAAT screening identified additional STI in patients with no symptoms recorded, that were not detectable by serology alone.
Authors
- Isabel Mellado-Sola (ORCID: https://orcid.org/0000-0001-7042-8561)
- Talía Sainz (ORCID: https://orcid.org/0000-0002-5301-0945)
- Alfredo Maldonado-Barrueco (ORCID: https://orcid.org/0000-0002-1856-1725)
- Cristina Calvo (ORCID: https://orcid.org/0000-0002-6503-3423)
- Mario David Ruiz-Bastián (ORCID: https://orcid.org/0000-0001-9513-9395)
- Blanca Bravo (ORCID: https://orcid.org/0000-0001-8432-0703)
- Paula Rodríguez-Molino (ORCID: https://orcid.org/0000-0002-2259-0393)
- Inmaculada Quiles‐Melero (ORCID: https://orcid.org/0000-0001-5268-2902)
- Carlos Grasa
- Milagros García-López-Hortelano
- Sonia Milkova-Ivanova
Institutions
- Hospital Universitario La Paz (ES)
- Instituto de Salud Carlos III (ES)
- Hospital La Paz Institute for Health Research (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red Enfermedades Infecciosas (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- European Journal of Pediatrics
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1007/s00431-026-07549-3
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III
- European Regional Development Fund
- NextGenerationEU